Empowered Funds LLC grew its stake in FONAR Co. (NASDAQ:FONR – Free Report) by 5.3% during the third quarter, Holdings Channel.com reports. The fund owned 18,690 shares of the medical equipment provider’s stock after acquiring an additional 938 shares during the period. Empowered Funds LLC’s holdings in FONAR were worth $303,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in FONR. O Shaughnessy Asset Management LLC raised its position in FONAR by 38.9% in the first quarter. O Shaughnessy Asset Management LLC now owns 32,978 shares of the medical equipment provider’s stock valued at $704,000 after purchasing an additional 9,237 shares during the period. Linden Thomas Advisory Services LLC raised its holdings in shares of FONAR by 9.6% in the 2nd quarter. Linden Thomas Advisory Services LLC now owns 21,605 shares of the medical equipment provider’s stock valued at $346,000 after buying an additional 1,900 shares during the period. Acuitas Investments LLC raised its holdings in shares of FONAR by 142.1% in the 2nd quarter. Acuitas Investments LLC now owns 113,400 shares of the medical equipment provider’s stock valued at $1,814,000 after buying an additional 66,563 shares during the period. Inspire Advisors LLC lifted its stake in FONAR by 177.3% during the 2nd quarter. Inspire Advisors LLC now owns 28,344 shares of the medical equipment provider’s stock worth $454,000 after acquiring an additional 18,124 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in FONAR by 11.5% during the 2nd quarter. Renaissance Technologies LLC now owns 344,216 shares of the medical equipment provider’s stock valued at $5,507,000 after acquiring an additional 35,375 shares during the period. 50.64% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Separately, StockNews.com lowered shares of FONAR from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 16th.
FONAR Stock Down 0.1 %
NASDAQ:FONR opened at $16.42 on Tuesday. FONAR Co. has a 52 week low of $14.05 and a 52 week high of $24.05. The company has a fifty day simple moving average of $15.88 and a two-hundred day simple moving average of $16.25. The company has a market cap of $103.91 million, a price-to-earnings ratio of 11.79 and a beta of 1.19.
FONAR (NASDAQ:FONR – Get Free Report) last released its earnings results on Friday, September 27th. The medical equipment provider reported $0.13 EPS for the quarter. FONAR had a return on equity of 6.10% and a net margin of 9.41%. The firm had revenue of $25.94 million during the quarter.
FONAR Profile
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Further Reading
- Five stocks we like better than FONAR
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- ETF Screener: Uses and Step-by-Step Guide
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Conference Calls and Individual Investors
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding FONR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for FONAR Co. (NASDAQ:FONR – Free Report).
Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.